Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
1998; Massachusetts Medical Society; Volume: 339; Issue: 5 Linguagem: Inglês
10.1056/nejm199807303390502
ISSN1533-4406
AutoresKenneth G. Saag, Ronald Emkey, Thomas J. Schnitzer, Jacques P. Brown, Federico Hawkins, Stefan Goemaere, Gorm Thamsborg, Uri Liberman, Pierre D. Delmas, Marie‐Pierre Malice, Michelle Czachur, Anastasia G. Daifotis, Nancy E. Lane, Ricardo Correa-Rotter, Melissa Yanover, René Westhovens, Sol Epstein, Jonathan D. Adachi, Patrice E. Poubelle, José Melo‐Gomes, Jose Adolfo Rodriguez-Portales,
Tópico(s)Bone Metabolism and Diseases
ResumoOsteoporosis is a common complication of long-term glucocorticoid therapy for which there is no well-proved preventive or restorative treatment.
Referência(s)